NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
Back to search
Official data from USPTO
NEOMEDI PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEOMEDI PHARM
ST13
US500000097544257Class
5
Filing
97544257
Registration
7381990
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/07/2024
Trademark type
Word
Nice classes
5
Filing date
08/11/2022
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
05/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/29/2024
First use in commerce
02/29/2024
Drawing code
4
Owner type
03
Owner location
Gyeonggi-do, KR
Examiner
POMEROY-MURPHY, KAITLIN
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NEOMEDIPHARM Inc.
Representatives
Kisuk Lee HARNESS, DICKEY & PIERCE, PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Adhesive bandages; Bandages for dressings; Self adhesive dressings; Transparent film dressings; Wound dressings
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/05/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/04/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/03/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/03/2024
IUAF
USE AMENDMENT FILED
03/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/08/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2023
GNRT
NON-FINAL ACTION E-MAILED
06/12/2023
CNRT
NON-FINAL ACTION WRITTEN
06/12/2023
DOCK
ASSIGNED TO EXAMINER
05/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2022
NWAP
NEW APPLICATION ENTERED
08/15/2022
Continuous trademark protection
Get notified about every new filing that threatens NEOMEDI PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.